Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02401750 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery
A Phase 3 study of Pain, sponsored by Elite Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 163
- Enrollment target
- 5
- Study locations
NCT02401750: Completed Phase 3 study of Pain, sponsored by Elite Laboratories.
NCT02401750 is a Phase 3 study of Pain that has completed, run by Elite Laboratories. The registered enrollment target is 163 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (46% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02401750, a Phase 3 study of Pain, has completed, sponsored by Elite Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 163 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, Phase 3 study to evaluate the efficacy and safety of the administration of multiple doses of Oxycodone Hydrochloride plus Naltrexone Hydrochloride (a) or Oxycodone Hydrochloride plus Naltrexone Hydrochloride (b) in patients who have undergone primary, unilateral, distal first metatarsal bunionectomy with osteotomy and internal fixation.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Oxycodone Naltrexone (a)
- DRUG Oxycodone Naltrexone (b)
Study Locations (5)
Texas
- Premier Research - Austin
- Endeavor Clinial Trials - San Antonio
Arizona
- Premier Research - Phoenix
Maryland
- Chesapeake Research Group - Pasadena
Utah
- Jean Brown Research - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2015-06 |
| Est. Completion | 2015-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02401750
The ClinicalTrials.gov registry entry for NCT02401750 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (46% lower). The listed sponsor is Elite Laboratories, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02401750 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Texas, Arizona, Maryland.
Frequently Asked Questions
What is clinical trial NCT02401750 about?
NCT02401750 is a clinical study titled "A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery". This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, Phase 3 study to evaluate the efficacy and safety of the administration of multiple doses of Oxycodone Hydrochloride plus Naltrexone Hydrochloride (a) or Oxycodone Hydrochloride plus Naltrexone Hydrochloride (b) in ...
What is the current status of trial NCT02401750?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 163 participants. The study started on 2015-06. Estimated completion is 2015-09.
What conditions does trial NCT02401750 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT02401750?
The interventions under investigation include: Placebo (DRUG), Oxycodone Naltrexone (a) (DRUG), Oxycodone Naltrexone (b) (DRUG).
Who is sponsoring clinical trial NCT02401750?
This trial is sponsored by Elite Laboratories, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02401750 being conducted?
This trial has 5 study locations across Arizona, Maryland, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.